Form D · Other Technology
Electronic Drug Information Systems Solutions LLC
St Louis, MO · CIK 0001612976
Offering snapshot reported Mar 15, 2016 · SEC filing
- Reported sold
- $504K Offering amount: $750K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 27, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$100,000 → $503,700
- Reported investors2 → 10
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 15, 2016 | Amendment | $503,700 | $403,700vs Jul 9, 2014 | 10 | SEC filing |
| Jul 9, 2014 | Initial | $100,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-220647
Source: Form D, filed Mar 15, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nannette Musgrave | Executive |
| Peter Yurkovich | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
C/O Bal 4320 Forest Park Ave Suite 304
St Louis, MO, 63108
St Louis, MO, 63108